Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins.

Resting lymphocytes are refractory to gene transfer using Moloney murine leukemia virus (MMLV)-based retroviral vectors because of their quiescent status. Recently, it has been shown that lentiviral vectors are capable of transferring genes into nondividing and terminally differentiated cells. We used human immunodeficiency virus type-1 (HIV-1)-based vectors expressing enhanced green fluorescent protein (EGFP) driven by different promoters (CMV, MPSV, or PGK) and investigated their ability to transduce human T- and B-cell lines, as well as resting or activated primary peripheral and umbilical cord blood lymphocytes. The effects of the presence or the absence of HIV-1 accessory proteins (Vif, Vpr, Vpu, and Nef) in the vector system were also assessed. Flow cytometry analysis showed no differences in the ability of these vectors of transferring the reporter gene into lymphocytic lines and mitogen-stimulated primary lymphocytes in the presence or the absence of HIV-1 accessory proteins (APs). Similarly, viral supernatants generated in the presence of accessory genes could efficiently transduce various subsets of resting lymphocytes and provide long-term expression of the transgene. No significant transduction-induced changes in cell activation or cycling status were observed and Alu-HIV-1 long terminal repeat polymerase chain reaction (LTR PCR) analysis demonstrated integration of the vector sequences at the molecular level. In contrast, in the absence of HIV-1 APs, lentiviral vectors failed to integrate and express the transgene in resting lymphocytes. These results show that transduction of primary resting lymphocytes with HIV-1-based vectors requires the presence of viral accessory proteins. (Blood. 2000;96:1309-1316)

[1]  D. Kohn,et al.  Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector. , 1999, Blood.

[2]  D. Richman,et al.  Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. , 1999, Science.

[3]  V. Sasseville,et al.  HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages , 1999, Nature Medicine.

[4]  Anthony S. Fauci,et al.  Both Memory and CD45RA+/CD62L+ Naive CD4+ T Cells Are Infected in Human Immunodeficiency Virus Type 1-Infected Individuals , 1999, Journal of Virology.

[5]  D. Littman,et al.  Cytokine Signals Are Sufficient for HIV-1 Infection of Resting Human T Lymphocytes , 1999, The Journal of experimental medicine.

[6]  M Geyer,et al.  Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. , 1999, Molecular cell.

[7]  A. McMichael,et al.  Induction of Fas Ligand Expression by HIV Involves the Interaction of Nef with the T Cell Receptor ζ Chain , 1999, The Journal of experimental medicine.

[8]  D. Trono,et al.  Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery , 1998, Journal of Virology.

[9]  M. Malim,et al.  HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. , 1998, Science.

[10]  B. Cullen HIV-1 Auxiliary Proteins: Making Connections in a Dying Cell , 1998, Cell.

[11]  B. Walker,et al.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.

[12]  M A Nowak,et al.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Peterson,et al.  Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors , 1997, Nature Genetics.

[14]  F. Gage,et al.  Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Luigi Naldini,et al.  Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo , 1997, Nature Biotechnology.

[16]  P. Walker,et al.  TCR analysis reveals significant repertoire selection during in vitro lymphocyte culture. , 1997, International immunology.

[17]  J. Belmont,et al.  Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene. , 1997, Human gene therapy.

[18]  S. Karlsson,et al.  Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Cheng‐Mayer,et al.  Activation of PAK by HIV and SIV Nef: importance for AIDS in rhesus macaques , 1996, Current Biology.

[20]  F. Gage,et al.  Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  C. Cheng‐Mayer,et al.  HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis. , 1996, Virology.

[22]  M. Malim,et al.  The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes , 1996, Journal of virology.

[23]  M. Tremblay,et al.  The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. , 1996, Virology.

[24]  F. Gage,et al.  In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.

[25]  M. Stevenson Pathway to understanding AIDS , 1996, Nature Structural Biology.

[26]  F. Lemonnier,et al.  Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein , 1996, Nature Medicine.

[27]  S. Rosenberg,et al.  T Lymphocyte-Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years , 1995, Science.

[28]  Evelina Mazzolari,et al.  Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA− Immunodeficient Patients , 1995, Science.

[29]  J. Hildreth,et al.  HIV acquires functional adhesion receptors from host cells. , 1995, AIDS research and human retroviruses.

[30]  D. Trono,et al.  Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis , 1995, Journal of virology.

[31]  S. Zolla-Pazner,et al.  Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1 , 1995, The Journal of experimental medicine.

[32]  D. Trono,et al.  HIV accessory proteins: Leading roles for the supporting cast , 1995, Cell.

[33]  C. Castilletti,et al.  HIV type 1 grown on interferon gamma-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells. , 1995, AIDS research and human retroviruses.

[34]  D. Richman,et al.  Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro , 1995, Journal of virology.

[35]  F. Rey,et al.  Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps , 1995, Journal of virology.

[36]  D. Baltimore,et al.  Proline‐rich (PxxP) motifs in HIV‐1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down‐regulation of CD4. , 1995, The EMBO journal.

[37]  R. Seder Acquisition of lymphokine-producing phenotype by CD4+ T cells. , 1994, The Journal of allergy and clinical immunology.

[38]  C. Cheng‐Mayer,et al.  HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. , 1994, Immunity.

[39]  D. Trono,et al.  The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Emerman,et al.  The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[41]  C. Bordignon,et al.  Peripheral Blood Lymphocytes as Target Cells of Retroviral Vector-Mediated Gene Transfer , 1994 .

[42]  D. Trono,et al.  Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells , 1993, Journal of virology.

[43]  J. Sodroski,et al.  Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes , 1992, Journal of virology.

[44]  M. Stevenson,et al.  HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.

[45]  Jerome A. Zack,et al.  HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.

[46]  A. Fisher,et al.  The sor gene of HIV-1 is required for efficient virus transmission in vitro. , 1987, Science.

[47]  C. Cheng‐Mayer,et al.  Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. Cheynier,et al.  Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. , 1986, Science.

[49]  S. Rosenberg,et al.  Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen. , 1995, Blood.

[50]  P. Sova,et al.  The human immunodeficiency virus type 1 vif gene: the road from an accessory to an essential role in human immunodeficiency virus type 1 replication. , 1995, Current topics in microbiology and immunology.

[51]  W. Telford,et al.  Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. , 1992, Cytometry.

[52]  J. Hoxie,et al.  Nonrandom association of cellular antigens with HTLV-III virions. , 1987, Human immunology.